Cheiron is building the operating system for drug programs. The company's AI-native platform helps biopharma teams represent, reason over, and stress-test the full state of a drug development program - including the claims, evidence, assumptions, risks, decisions, and commitments that determine whether a therapy advances. Powered by its proprietary Life Sciences Knowledge Graph, Cheiron supports teams across clinical, regulatory, competitive intelligence, and program leadership workflows. Founded in 2024 by Stanford-trained AI researchers and biopharma operators.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
07/23/26	$8,000,000	Seed	Menlo Ventures	undisclosed